Most Kwai Chung Limited announced that with effect from the close of the Offer on April 23, 2026, Dr. Ma Liyang shall be appointed as an executive Director. Dr. Ma, aged 51, has 13 years? experience in product marketing and public relations management, and 14 years?
experience in investing in and operating PRC-based hi-tech environmental protection enterprises engaged in the clean utilization and harmless environmental protection treatment of heavy metal-containing solid hazardous wastes. He serves as chairman of the board of directors of Kingland Technology Co. Ltd., the shares of which are listed on the Shenzhen Stock Exchange for trading, from January 2024 to now.
He has successively served as vice president, deputy vice president, and chief executive officer from January 2012 to September 2015, and controlling shareholder, chairman of the board of directors and chief executive officer from September 2015 to now, of Greennovo Environmental Technology Co. Ltd. He also serves as the director of Greennovo?s joint research centre with Tsinghua Suzhou Environmental Innovation Research Institute for hazardous waste treatment technology from May 2019 to now. Prior to joining Greennovo, from June 1998 to December 2011, Dr. Ma served on various management positions at Lenovo, Fuji Xerox, NEC and Lanxum in the PRC successively, at which he was responsible for product marketing and public relations management.
Dr. Ma obtained a double bachelor?s degree in automotive engineering and business administration from the Department of Automotive Engineering and the School of Economics and Management, Tsinghua University in July 1996; a master?s degree in Industrial Engineering from the School of Economics and Management, Tsinghua University in June 1998; and a doctoral degree in Engineering from the School of Environment, Tsinghua University in December 2025. Most Kwai Chung Limited further announced that Dr. Chen Yang shall be appointed as an independent non-executive Director and a member of each of the audit committee, the nomination committee and the remuneration committee of the Board with effect from the close of the Offer on April 23, 2026. Dr. Chen, aged 47, has more than 20 years of experience in investment management.
Since June 2025, Dr. Chen is an independent non-executive director of Besunyen Holdings Company Limited, a company whose shares are listed on the Stock Exchange. Since June 2024, Dr. Chen is the vice chairman of Laboratory for Advanced Medicine & Health Inc. Since 2018, Dr. Chen is a director of Beijing Jinxiu Dadi Agriculture Co. Ltd. Between July 2005 and July 2013, he worked for China Minzu Securities Co.
Ltd. and lastly as the general manager of compliance department. Between July 2013 and May 2015, Dr. Chen was a specialist of China Association for Public Companies. Between May 2015 and September 2018, he served as the inspector general of Sinvo Fund Management Co.
Ltd. Dr. Chen graduated from China University of Political Science and Law in 2004 with a bachelor?s degree in law. He obtained a master?s degree in business administration from Temple University in 2018 and a doctoral degree in business administration from Temple University in 2021. Most Kwai Chung Limited announced that Mr. Leung Wai Man has tendered his resignation as an independent non-executive Director and a member of each of the audit committee, the nomination committee and remuneration committee of the Board with effect from the close of the Offer on April 23, 2026 due to devotion of more time to pursue his other commitments.
Most Kwai Chung Limited announced that Mr. Iu Kar Ho has resigned as the chairman of the Board with effect from the close of the Offer on April 23, 2026 due to devotion of more time to pursue his other commitments. Mr. Iu will remain as an executive Director. The Board further announced that Dr. Ma shall be appointed as the chairman of the Board with effect from the close of the Offer on April 23, 2026.
